Tinton Falls, New Jersey, October 17, 2006: Pressure Right, a new non-invasive acupressure adhesive wristband, has been found to inhibit the effects of delayed nausea and vomiting caused by chemotherapy (CINV).
New Acupressure Adhesive Wristband Successfully Prevents Delayed Nausea Caused By Chemotherapy: Oncology Patients Are Invited To Participate in New Study
Tinton Falls, New Jersey, October 17, 2006: Pressure Right™, a new non-invasive acupressure adhesive wristband, has been found to inhibit the effects of delayed nausea and vomiting caused by chemotherapy (CINV).
Joseph DiLustro, CEO and President of Therapeutics: 101 Inc., the manufacturer and distributor of Pressure Right™ estimates, “At least 350,000 – or 27 percent of chemo patients – are at risk in getting delayed chemo-induced nausea and vomiting, which usually lasts between 2 and 5 days after treatment, even though they are given anti-nausea medication. Pressure Right™ has an inhibitory effect on prolonged CINV and produces no adverse side effects, including the absence of potential circulation problems.”
Rick Glover, a chemotherapy patient who had colon cancer surgery in April 2006, states, “I was given anti-nausea medication to help with delayed nausea & vomiting caused by chemotherapy, but they only worked part of the time. Then I wore Pressure Right™ wristbands for several days after each IV and oral chemotherapy treatment in between my anti-nausea medication. Pressure Right™ took away the feeling of nausea.”
“I just completed an intensive 5-month IV and oral chemotherapy treatment cycle for my stage two cancer. Based on my personal experience, I would recommend that cancer patients receiving chemotherapy use Pressure Right™ with their anti-nausea medication from day one through day five for each treatment,” adds Glover.
Pressure Right™ is hypoallergenic, water safe and very cost-effective. The band’s stimulation process begins immediately and has no limited time frame in helping to combat the incidence and intensity of post-chemotherapy nausea and vomiting.
Pressure Right™ also provides extended relief from postoperative nausea and vomiting (PONV) for high-risk patients following surgery for at least 48 hours. Dr. Mark Shulman, program director of anesthesiology and pain management at Caritas St. Elizabeth’s Medical Center in Boston says, “People at high-risk for N&V post-operatively and in the period after they go home have had good results using the Pressure Right™ wristbands.”
About Therapeutics: 101 Inc.
The Company focuses primarily on preventing delayed nausea and vomiting caused by chemotherapy (CINV), as well as postoperative nausea and vomiting (PONV) caused by surgery with the use of its patent-pending, cost-effective, acupressure adhesive wristband. Pressure Right™ is a registered trademark of Therapeutics: 101 Inc. and is currently made in the USA.
Therapeutics: 101, Inc. will be conducting a short, blinded study consisting of one and two treatment cycles of chemotherapy to measure the overall efficacy of the wristband. The study will focus on IV therapy for new chemotherapy patients as well as patients who have changed their treatment. A cycle of chemotherapy usually ranges from 21 to 28 days. To participate in the study, or for additional information, please contact Therapeutics: 101, Inc.
Contact:
Joseph DiLustro
CEO& President
Therapeutics: 101 Inc.
Tel: (908) 601-8877
Email:
This email address is being protected from spam bots, you need Javascript enabled to view it
This email address is being protected from spam bots, you need Javascript enabled to view it
###
|
About the Press Release
Tinton Falls, New Jersey, October 17, 2006: Pressure Right, a new non-invasive acupressure adhesive wristband, has been found to inhibit the effects of delayed nausea and vomiting caused by chemotherapy (CINV).
|
|
Download PDF Version
Email this story to a colleague
Printer Friendly Version
